Alabama Repackager Warned Over Misbranding

Drug Industry Daily
A A
The FDA has issued a warning letter to Rainbow Gold Products in Sardis City, Ala., a drug repackaging and relabeling facility, for products containing a misbranded and mislabeled drug.

To View This Article:

Login

Subscribe To Drug Industry Daily